# Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-or-dapagliflozin-plus-saxagliptin-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Dirk Müller‐Wieland,Monika Kellerer,Katarzyna Cypryk,Dasa Skripova,Katja Rohwedder,Eva Johnsson,Ricardo García‐Sánchez,Raisa Kurlyandskaya,C. David Sjöström,Stephan Jacob,Jochen Seufert,Nalina Dronamraju,Katalin Csomós |
| Citations | 73 |
| DOI | 10.1111/dom.13437 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13437 |
| OpenAlex ID | https://openalex.org/W2810092615 |
| PMID | 29947099 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Katja Rohwedder](https://scholariq.org/researchers/katja-rohwedder/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.